Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Resin hemoperfusion: a method of removing circulating thyroid hormones.

K D Burman, H C Yeager, W A Briggs

    The Journal of Clinical Endocrinology and Metabolism
    |January 1, 1976
    PubMed
    Summary

    This study shows that hemoperfusion using Amberlite resin effectively lowers thyroid hormones (T3, T4, FT4) in thyrotoxic dogs. This extracorporeal method offers a potential safe treatment for thyroid storm in humans.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Novel biomarker <i>SYT12</i> may contribute to predicting papillary thyroid cancer outcomes.

    Future science OA·2017
    Same author

    A 2013 European survey of clinical practice patterns in the management of Graves' disease.

    Clinical endocrinology·2015
    Same author

    Reprint of: policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al.

    Hormones and behavior·2013
    Same author

    Reprint of: policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich, et al.

    Frontiers in neuroendocrinology·2013
    Same author

    Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al.

    Andrology·2013
    Same author

    Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al.

    Hormone research in paediatrics·2013

    Area of Science:

    • Veterinary Medicine
    • Endocrinology
    • Nephrology

    Background:

    • Thyrotoxicosis is a condition characterized by excessive thyroid hormones.
    • Current treatments for severe thyrotoxicosis, like thyroid storm, can have significant side effects.
    • Extracorporeal hemoperfusion offers a potential alternative for rapid hormone reduction.

    Purpose of the Study:

    • To evaluate the efficacy of an extracorporeal hemoperfusion system using Amberlite resin.
    • To determine the system's ability to bind and remove thyroid hormones (T3, T4, FT4) from circulation.
    • To assess the safety and potential application of this method in thyrotoxic dogs.

    Main Methods:

    • Thyrotoxicosis was induced in dogs via intramuscular thyroid hormone administration.

    Related Experiment Videos

  • An extracorporeal hemoperfusion system with neutral Amberlite resin was used.
  • Control perfusions were performed to account for hemodilution effects.

    • Main Results:

    • Hemoperfusion significantly decreased serum triiodothyronine (T3) by 39%, thyroxine (T4) by 35%, and free thyroxine (FT4) by 46% after 2 hours.
    • Calculated hormone clearance rates indicated substantial removal of T3 and T4.
    • No significant changes in hematologic indices or routine chemistries were observed, except for minor albumin and glucose level alterations.

    Conclusions:

    • Extracorporeal hemoperfusion with Amberlite resin is a safe and effective method for reducing circulating thyroid hormone levels in thyrotoxic dogs.
    • This hemoperfusion system demonstrates potential as a therapeutic option for managing thyroid storm in humans.
    • Further evaluation is warranted to explore its clinical applicability in human medicine.